BOK Financial Private Wealth Inc. Buys 620 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

BOK Financial Private Wealth Inc. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,918 shares of the healthcare conglomerate’s stock after purchasing an additional 620 shares during the period. UnitedHealth Group accounts for about 0.6% of BOK Financial Private Wealth Inc.’s portfolio, making the stock its 27th biggest position. BOK Financial Private Wealth Inc.’s holdings in UnitedHealth Group were worth $8,628,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. NorthCrest Asset Manangement LLC boosted its holdings in UnitedHealth Group by 9.5% in the first quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock worth $264,000 after acquiring an additional 45 shares in the last quarter. Domani Wealth LLC boosted its stake in UnitedHealth Group by 0.7% during the first quarter. Domani Wealth LLC now owns 3,542 shares of the healthcare conglomerate’s stock valued at $1,806,000 after buying an additional 25 shares during the period. Stratos Wealth Partners LTD. raised its position in UnitedHealth Group by 44.0% during the first quarter. Stratos Wealth Partners LTD. now owns 17,711 shares of the healthcare conglomerate’s stock valued at $9,032,000 after purchasing an additional 5,414 shares in the last quarter. Salvus Wealth Management LLC raised its position in UnitedHealth Group by 23.5% during the first quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock valued at $399,000 after purchasing an additional 149 shares in the last quarter. Finally, Lake Street Financial LLC raised its position in UnitedHealth Group by 42.9% during the first quarter. Lake Street Financial LLC now owns 3,706 shares of the healthcare conglomerate’s stock valued at $1,890,000 after purchasing an additional 1,112 shares in the last quarter. Institutional investors own 87.48% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Royal Bank of Canada set a $563.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a research report on Monday, April 18th. SVB Leerink lifted their price objective on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Cowen lifted their price objective on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Credit Suisse Group lifted their price objective on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $549.00 to $556.00 in a report on Tuesday, July 19th. Three equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $582.50.

Insider Buying and Selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction dated Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total transaction of $635,227.00. Following the sale, the executive vice president now owns 8,104 shares in the company, valued at $4,043,896. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the sale, the director now directly owns 1,215,000 shares of the company’s stock, valued at $581,936,400. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,273 shares of the firm’s stock in a transaction that occurred on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total transaction of $635,227.00. Following the completion of the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The disclosure for this sale can be found here. Insiders sold a total of 130,144 shares of company stock valued at $69,269,555 in the last ninety days. Insiders own 0.40% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH traded up $6.73 during mid-day trading on Tuesday, hitting $543.33. 47,806 shares of the company were exchanged, compared to its average volume of 2,797,499. UnitedHealth Group Incorporated has a 1-year low of $383.12 and a 1-year high of $553.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.77 and a current ratio of 0.77. The company has a 50 day moving average of $507.05 and a 200-day moving average of $500.49. The stock has a market cap of $508.22 billion, a price-to-earnings ratio of 28.02, a price-to-earnings-growth ratio of 1.66 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. During the same period last year, the business earned $4.70 EPS. The company’s revenue was up 12.6% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 21.86 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were given a $1.65 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date was Thursday, June 16th. UnitedHealth Group’s dividend payout ratio is presently 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.